Novavax Inc (NVAX)
$134.99
0.00 (0.00%)
NVAX Stock Quote Delayed 30 Minutes
Novavax is Now a Riskier Play, but Still One to Keep Your Eye On
NVAX stock is even more of a gamble thanks to manufacturing issues, but the next move for the beaten-down shares could still be up.
Louis Navellier's Top 6 Stocks for 2021
He found Apple at $1.49… Intel at $3.60... Amazon at $46. Now, investing legend Louis Navellier is revealing his Top 6 Stocks for 2021 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
10.05B
PE Ratio
-9.72
EPS
-13.89
Volume (Avg. Vol.)
669,768
Day's Range
134.99 - 134.99
52-Week Range
76.59 - 331.68
Dividend & Yield
N/A (N/A)
NVAX Stock Predictions, Articles, and Novavax Inc News
It’s Time to Secure Those Profits You Earned from Novavax
While NVAX stock had an excellent run, the vaccination market is practically saturated, meaning investors should consider profit-taking.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
I hope you're ready for another busy day of trading because we're starting it with the biggest pre-market stock movers for Wednesday.
Novavax Stock Fortunes Are Still Awaiting the Magical Headline
NVAX stock is up 3,480% in two years but the real price fight is awaiting headlines from management. Meanwhile, owning it requires conviction.
Novavax Will Be Volatile Until the Company Delivers Answers
NVAX stock has been making some volatile moves in 2021. And that volatility will continue until its Covid-19 vaccine gets regulatory approval.
Novavax Stock Will Find Its Bottom, But Probably not Soon
Down nearly 40% over the past month, NVAX stock has been on a steep decline that appears to be accelerating. At its current price of $163.06 per share, Novavax's stock is now 50% below its all-time high of $331.68 reached in February of this year. With the current slide showing no signs of stopping, shareholders may want to cut their losses.
Novavax Stock Got Merck-ed, but Don’t Dump Your Shares Now
NVAX stock still has plenty of value as Novavax has a rich and diverse clinical pipeline, including a promising influenza vaccine candidate.
Novavax Stock Looks Interesting as the World Still Needs Vaccines
There are plenty of reasons to stay invested in NVAX stock as the Delta variant forces a renewal of fortunes for the vaccine also-ran.
Once-Cinderella Novavax Stock Could Be Poisoned by Merck’s Covid Pill
With a new oral antiviral drug by Merck potentially over the horizon, NVAX stock may be trading on borrowed time.
Latest Bad News Suggests Novavax Stock Might Be Cursed
Merck’s experimental oral Covid-19 antiviral drug is not good news for Novavax or NVAX stock. It might be time to reconsider your bet.
Merck’s Good News Doesn’t End the Bullish Story for Novavax
Investors are pointing fingers at Merck, but a tricky start to October could yet turn into a treat for buyers of NVAX stock
Despite Game-Changing Treatment News, It’s Not Over for Novavax Yet
Merck's Covid-19 treatment pill may have changed the story for NVAX stock. However, if it tumbles further, the stock could become a buy again.
4 Top Stock Trades for Monday: BTC, ETH, NVAX, MRNA
Bitcoin, Ethereum, Novavax and Moderna were our top stock trades for Monday. Now, let's look at how the charts are setting up for next week.
Vaccine Stocks: Why MRNA, VXRT, CVAC and NVAX Stocks Need a Band-Aid Today
Today, vaccine stocks are taking a massive hit as investors price in the potential effect of oral medications for Covid-19 on this sector.
Novavax News: Why NVAX Stock Investors Have a Tough Pill to Swallow Today
Novavax (NVAX) stock is taking a beating on Friday as investors react to news about Merck (MRK) developing a COVID-19 treatment.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Good morning, investor! The final day of the workweek is here and with it comes a look at the pre-market stock movers for Friday!
Novavax Stock is Set to Soar in the Year Ahead
The potential rewards in NVAX stock far outweigh the risks as the vaccine maker awaits regulatory approval from the WHO and others.
Novavax Stock Needs a Longer Pandemic as Investor Patience Wears Thin
Novavax has always been a volatile stock, as Covid-19 is its big chance for success. In the end, NVAX stock remains a speculation.
Novavax Is Looking More and More Like It Has Moderna-Type Potential
NVAX stock has languished as FDA approval seemed less likely. But that has all changed now. Novavax is almost certainly headed higher.
NVAX Stock: 2 Big Reasons Novavax Is Sliding Lower Today
Today, investors in Novavax are seeing a lot of red due to a key catalyst that's taking NVAX stock significantly lower.
